|
|
Commonwealth Biotechnologies, Inc. - Earning & Dividend Analysis Snapshot
This detailed Report provides an Earnings and Dividends history for Commonwealth Biotechnologies, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
Commonwealth Biotechnologies, Inc.. The Group's principal activity is to provide solutions to the global biotechnology industry, academic institutions, genetic identity, laboratory services, commercial contracts, government agencies and pharmaceutical companies. It provides integrated contract research support in four principal areas: bio-defense; laboratory support services for on-going clinical trials; comprehensive contract projects in the private sector; and through it FIL division, for paternity testing, forensic case-work analysis and CODIS work. The Group also provides sophisticated macromolecular synthetic and analytical services, integrating individual platform technologies. The Group facilitates strategic decisions to both short term and long term clients. It operates only in the United States. On 23-Sep-2008, the Group discontinued Exelgen Limited.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|